
Researchers have mapped how the body’s own peptides (here in orange/yellow) bind to a receptor complex to suppress infection/inflammation. (Image: Suppl Fig 12 Nature Communications doi.org/10.1038/s41467-018-05242-0)
Researchers at Lund University in Sweden, have in collaboration with colleagues in Copenhagen and Singapore, mapped how the body’s own peptides act to reduce infection and inflammation by deactivating the toxic substances formed in the process.
The study is published in Nature Communications and the researchers believe their discovery could lead to new drugs against infection and inflammation, for example in wound healing.
The toxins that are neutralised, known as lipopolysaccharides (LPS), come from the bacterial cell walls and generate an inflammatory reaction. The reaction is a necessary part of our immune defence system in which our bodies respond quickly and fight invasive bacteria. However, it can be over-activated and become harmful, as observed in infected skin wounds, infections in various organs, or in the case of bacteria spreading to the blood, which can lead to sepsis.
“We know from previous studies what the task of these peptides is but now we have mapped how they proceed in gradually reducing an inflammatory reaction”, says Artur Schmidtchen, professor of dermatology and venereology at Lund University and consultant physician at Skåne University Hospital in Lund.
“By use of advanced biophysics such as nuclear magnetic resonance analysis, combined with molecular modelling and biological studies we show that these peptides form a C-shaped structure which enables the capturing and inactivation of LPS. They also simultaneously interfere with receptor-mediated inflammatory responses”, adds Rathi Saravanan, senior research fellow at Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore, and first author of the study.
“Currently, most drugs aim to more or less completely block a target, such as a receptor. But that risks a deactivation of the immune defence system which can be detrimental and downright dangerous. The body’s own defence mechanisms proceed with greater caution in what is known as a transient manner: the peptides act on their target for a short time to reduce an inflammation towards normalisation. It is the natural functions of these peptides that we want to develop into new drugs”, says Artur Schmidtchen, who has been researching the field of innate immunity for over 20 years.
In addition, the peptides present in thrombin, a common blood protein, are multifunctional and can attack several targets, unlike current drugs.
The dermatology researchers now want to develop a peptide gel for improved wound healing in patient studies.
“That is the primary goal, but we will also be looking at the possibility of developing new drugs against infections in the eyes and various internal organs. This will become a new way of preventing both infection and inflammation without using antibiotics.”
Learn more: The medicine of the future against infection and inflammation?
The Latest on: Peptides
via Google News
The Latest on: Peptides
- Global Biosimilar Therapeutic Peptides Market Report 2020: Market is Expected to Recover by 2023 as a CAGR of 30.48% - Forecast to 2030on January 11, 2021 at 6:00 am
DUBLIN, Jan. 11, 2021 /PRNewswire/ -- The "Biosimilar Therapeutic Peptides Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.
- Fish Collagen Peptides Market Outlook 2022 Projections | GELITA AG and Amicogenon January 11, 2021 at 5:59 am
A recent business intelligence market study announced by Market.us on “ Fish Collagen Peptides Market Future Trends, Revenue Growth, Profitability and Leading Players To 2031 “, that reveals diverse ...
- Global Biosimilar Therapeutic Peptides Market Report 2020: Market is Expected to Recover by 2023 as a CAGR of 30.48% - Forecast to 2030on January 11, 2021 at 5:45 am
The "Biosimilar Therapeutic Peptides Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.
- Global Biosimilar Therapeutic Peptides Market Report 2020-2030 - ResearchAndMarkets.comon January 8, 2021 at 4:29 am
The “Biosimilar Therapeutic Peptides Global Market Report 2020-30: COVID-19 Growth and Change” report has been added to ResearchAndMarkets.com’s offering. Biosimilar Therapeutic Peptides Global Market ...
- Global Biosimilar Therapeutic Peptides Market Report 2020: COVID-19 Impacts, Growth and Changes - Forecast to 2030on January 7, 2021 at 7:02 am
The "Biosimilar Therapeutic Peptides Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. Biosimilar Therapeutic Peptides Global Market ...
- Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus ACAT Model for Oral Absorption of Peptideson January 6, 2021 at 12:48 am
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it ...
- Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus® ACAT™ Model for Oral Absorption of Peptideson January 5, 2021 at 5:48 am
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, ...
- How Peptides Are Madeon December 20, 2020 at 4:01 pm
What does body building, anti-aging cream and Bleomycin (a cancer drug) have in common? Peptides of course! Peptides are large molecules that are vital to life. If you were to take a protein and ...
- Peptides: the wonder ingredient set to bolster your skincare routineon December 17, 2020 at 1:00 am
Looking for a better performance from your skincare? Behold the power of peptides. Here’s everything you need to know about the wonder ingredient that’s set to bolster your routine ...
via Bing News